| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.7B | $0.6B | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | $0.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Operating Income | $0.2B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.75 | $1.23 | $3.48 | $2.24 | $1.45 | $1.44 | $1.19 | $0.76 |
| EPS (Diluted) | $1.73 | $1.21 | $3.45 | $2.21 | $1.43 | $1.41 | $1.16 | $0.76 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9B | $2.1B | $1.1B | $1.1B | $1.1B | $1.0B | $0.9B | $0.9B |
| Current Assets | $0.5B | $0.6B | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B |
| Cash & Equivalents | $0.3B | $0.3B | $0.2B | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $1.3B | $1.4B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.8B |
| Current Liabilities | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Stockholders' Equity | $0.5B | $0.6B | $0.5B | $0.5B | $0.3B | $0.3B | $0.2B | $0.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | $-0.1B | $-0.5B | $-0.1B | $-0.1B | $-0.0B | $-0.1B | $-0.0B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $0.4B | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |